Friday, 4 September 2026European Markets
ExploreSearch
ViaNews EU
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· April 28, 2026

Is Novo Nordisk (CPSE:NOVO B) Pricing Reflect Its Recent Share Price Swings And Growth Outlook

View original at finance.yahoo.com
Is Novo Nordisk (CPSE:NOVO B) Pricing Reflect Its Recent Share Price Swings And Growth Outlook Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Sell-side analysts have provided explicit Free Cash Flow forecasts for Novo Nordisk out to 2030, with Simply Wall St extrapolating further to 2035

    60% confidence

  • Novo Nordisk projected Free Cash Flow reaches DKK 107.4 billion by 2030

    60% confidence

  • Novo Nordisk scores 5 out of 6 on Simply Wall St's valuation checks

    60% confidence

  • Novo Nordisk's 34.5% return over the last year is lagging behind its pharmaceutical peers

    60% confidence

  • Novo Nordisk is undervalued by 65.4% based on DCF analysis, with an intrinsic value of DKK 769.11 per share

    60% confidence

  • Novo Nordisk extrapolated Free Cash Flow reaches approximately DKK 145.9 billion by 2035

    60% confidence

  • Investors have been reassessing Novo Nordisk's growth expectations and risk, shifting sentiment and explaining the mix of short-term gains and long-term declines

    60% confidence

  • 237 more high quality undervalued stocks are identified on Simply Wall St's platform

    60% confidence

Data points we hold from this source

Novo Nordisk · free cash flow52.1 billion_DKK
Novo Nordisk · free cash flow projected107.4 billion_DKK
Novo Nordisk · free cash flow extrapolated145.9 billion_DKK
Novo Nordisk · dcf intrinsic value769.11 DKK_per_share
Novo Nordisk · discount to intrinsic value65.4 percent
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Funding Surge: Capital Floods Fintech, Foundation Models, and Autonomous Systems
A concentrated burst of AI-linked funding on 2026-08-28 pushed well over $1.5B into companies spanning fraud/identity fintech (Socure, which also acquired Fravity), foundation models (Stability AI), AI agents and enterprise tooling (Instinct, Generalist AI, Emerald AI, Owner), and AI-adjacent autonomous/aerospace ventures (Gatik, Regent Craft). The breadth and simultaneity of these rounds signal that investor appetite for AI is not concentrated in a single vertical but is broadening into applied and infrastructure-adjacent domains, with consolidation (Socure-Fravity) beginning alongside fresh capital formation.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,269 source documents archived
Query this data → isubstrate.com
Is Novo Nordisk (CPSE:NOVO B) Pricing Reflect Its Recent Share Price Swings And Growth Outlook — Source | Via News | ViaNews EU